2019
Omics and coagulation disorders in pregnancy
Ornaghi S, Paidas M. Omics and coagulation disorders in pregnancy. 2019, 149-155. DOI: 10.1201/9781315201955-24.Peer-Reviewed Original ResearchFetal growth restrictionOmics technologiesPlacenta-mediated complicationsMaternal thromboembolismSpecific biological sampleCoagulation disordersMolecular basisBiochemical pathwaysRegistry-based studyMessenger RNADifferent clinical conditionsVascular biologyPlacental abruptionFetal lossGrowth restrictionRisk factorsClinical conditionsLarge cohortNonbiased mannerBiomarker developmentThromboembolismPreeclampsiaComplicationsPregnancyRelevant diseases
2018
Venous thromboembolic disease
Ball B, Paidas M. Venous thromboembolic disease. 2018, 355-363. DOI: 10.1002/9781119072980.ch34.Peer-Reviewed Original Research
2014
Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Paidas M, Løkkegaard E. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis And Haemostasis 2014, 112 DOI: 10.1160/th-13-09-0797.Peer-Reviewed Original ResearchCombined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Paidas M, Løkkegaard E. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis And Haemostasis 2014, 112: 73-78. PMID: 24499991, DOI: 10.1160/th13-09-0797.Peer-Reviewed Original ResearchConceptsVenous thromboembolismHormonal contraceptivesIncidence ratiosFirst-time venous thromboembolismCrude incidence ratioCombined oral contraceptivesNationwide retrospective cohortConfirmed pregnanciesOral contraceptivesRetrospective cohortHormonal contraceptionPuerperal periodAbsolute riskWeeks postpartumDanish womenMAIN OUTCOMEThromboembolismPregnancyContraceptivesOne-yearUnique registryFirst yearRiskBirthRegistry
2013
347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD)
Paidas M, Triche E, James A, Ballard T, Lowry S. 347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD). American Journal Of Obstetrics And Gynecology 2013, 208: s154. DOI: 10.1016/j.ajog.2012.10.512.Peer-Reviewed Original ResearchOC-03 Oral contraception and risk of venous thromboembolism within the first year following pregnancy
Petersen J, Bergholt T, Nielsen A, Lidegaard Ø, Paidas M, Løkkegaard E. OC-03 Oral contraception and risk of venous thromboembolism within the first year following pregnancy. Thrombosis Research 2013, 131: s71. DOI: 10.1016/s0049-3848(13)70029-x.Peer-Reviewed Original Research
2008
Antithrombotic Therapy and Pregnancy: Consensus Report and Recommendations for Prevention and Treatment of Venous Thromboembolism and Adverse Pregnancy Outcomes
Duhl A, Paidas M, Ural S, Branch W, Casele H, Cox-Gill J, Hamersley S, Hyers T, Katz V, Kuhlmann R, Nutescu E, Thorp J, Zehnder J. Antithrombotic Therapy and Pregnancy: Consensus Report and Recommendations for Prevention and Treatment of Venous Thromboembolism and Adverse Pregnancy Outcomes. Obstetric Anesthesia Digest 2008, 28: 137-138. DOI: 10.1097/01.aoa.0000326376.74250.dd.Peer-Reviewed Original Research
2007
Do Thrombophilias Cause Placenta-Mediated Pregnancy Complications?
Rodger M, Paidas M. Do Thrombophilias Cause Placenta-Mediated Pregnancy Complications? Seminars In Thrombosis And Hemostasis 2007, 33: 597-603. PMID: 17768692, DOI: 10.1055/s-2007-985756.Peer-Reviewed Original ResearchConceptsPlacenta-mediated pregnancy complicationsPregnancy complicationsAnticoagulant prophylaxisIntrauterine growth restrictionThrombophilic pregnanciesNeonatal morbidityPlacental abruptionVenous thromboembolismThrombophilic womenPregnancy lossGrowth restrictionClinical consequencesHigh riskThrombophiliaComplicationsCausal associationProphylaxisAssociationThromboembolismAbruptionPreeclampsiaMorbidityEvidencePregnancyNew associationsThromboembolic Disorders of Pregnancy
Paidas M, Pettker C, Lockwood C. Thromboembolic Disorders of Pregnancy. 2007, 825-848. DOI: 10.1002/9780470753293.ch47.ChaptersRecurrent adverse pregnancy outcomesAdverse pregnancy outcomesVenous thromboembolismPregnancy outcomesPregnancy treatmentPregnancy managementRisk factorsRadiation exposureAnemia risk factorsThromboembolic disordersAnticoagulationThromboembolismPregnancyThrombophiliaSurgeryDiagnosisPharmacologyWomenOutcomesTreatmentExposure